Westminster, CA
-- March 3, 2021 -- InvestorsHub NewsWire
-- BioLargo, Inc. (OTCQB:BLGO),
a developer of sustainable
technologies and a full-service environmental engineering
company, today announced that it has been
invited
to present its
AOS (Advanced Oxidation System) water treatment
technology to decision-makers
from diverse multinational
companies at an Isle Utilities iTAG
event.
At Isle Utilities' iTAG
(Industrial Technology Approval Group) events, which are held three
times per year, water specialists,
sustainability/innovation managers and other experts from global
industries vote on promising water
technologies they would like to learn about. Some iTAG member companies
include Coca-Cola, Shell, and Proctor & Gamble.
In the March 2021
meeting, iTAG member companies
voted to learn
about BioLargo's AOS technology. BioLargo Director of
Strategic Marketing and Business Development Tonya Chandler will
present the BioLargo AOS to iTAG
member companies on March 4, 2021.
To learn more about the TAG
program, watch Isle Utilities' video: https://www.youtube.com/watch?v=iVEI-qWzqXM#action=share
BioLargo's ground-breaking
and patented Advanced Oxidation System (AOS) is a water treatment
platform that provides high-level disinfection and consumes less
electricity than competing technologies. Distinct from other
disinfection-focused treatment systems, the AOS can also
remove certain pharmaceutical
micropollutants from water to provide added value
across diverse
water treatment applications.
The timing of
BioLargo's
invitation to present at iTAG
is
auspicious, as the company is beginning
to roll out the AOS through commercial trials, beginning with
its first
farm-wide water
treatment and reuse project at a poultry farm in Alberta,
Canada.
To learn more about the
BioLargo AOS, visit www.biolargowater.com.
About Isle
Utilities and iTAG
Isle is a medium sized,
worldwide operating consultancy that has bridged exactly that gap
successfully over the past decade for more than 150 global
utilities. With 40 highly educated water professionals located all
over the globe, Isle scouts, assesses and selects new water related
technologies for the municipal water and wastewater utilities. In
2016, Isle has started to offer this service to industries with
water and sustainability challenges too. Each industrial
company has sustainability objectives but it is typical that not
all companies have the time to visit all the global trade shows,
read every journal on the subject and invite all salesmen to site
with that unique innovative solution to save water, energy and
chemicals. At the same time, business developers of new innovative
technologies have a hard time to draw the attention of these always
extremely occupied industries. It was a catch 22 situation, until
Isle set up iTAG.
Three times a year at
iTAG-meetings (industrial Technology Approval Group) water
specialists, sustainability/innovation managers and other experts
from global industries gather. Some weeks prior to this meeting the
members receive a list of the newest technological water related
solutions which have been thoroughly vetted and compactly described
by Isle's experts. The members are invited to vote on the most
promising technologies, which will be presented on the iTAG
meeting. Over the last 10 years Isle has evaluated over 100 new
technologies each year, varying from well protection technologies,
treatment technologies, innovative sensors to cooling water
technologies, wastewater solutions and novel ways to recover
nutrients, sludge and energy.
About
BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO)
invents, develops, and commercializes innovative platform
technologies to solve challenging environmental problems like PFAS
contamination, advanced water and wastewater treatment, industrial
odor and VOC control, air quality control, and infection control.
With over 13 years of extensive R&D,
BioLargo
holds a wide
array of issued patents, maintains a robust pipeline of products,
and provides full-service environmental
engineering. Our peer-reviewed scientific approach allows us to
invent or acquire novel technologies and develop them to maturity
through our operating subsidiaries. With a keen emphasis on
collaborations with academic, municipal, and commercial
organizations and associations, BioLargo has proven itself with over
80 awarded grants and numerous pilot projects. We monetize through
direct sales, recurring service contracts, licensing agreements,
strategic joint venture formation and/or the sale of the IP.
Several of our technologies are commercially available and are
advancing as disrupters in their respective markets.
See our website
at www.BioLargo.com.
Contact
Information
Dennis P. Calvert
President and
CEO, BioLargo, Inc.
888-400-2863
Safe Harbor
Act – caution regarding forward
looking statements
This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements include without limitation those about
BioLargo's
(the "Company") expectations regarding the
impact of the COVID-19 pandemic; anticipated
revenue; and plans for future
operations. These statements involve
risks and uncertainties, and actual results may differ materially
from any future results expressed or implied by the forward-looking
statements. Risks and uncertainties include without limitation: the
effect of the COVID-19 pandemic on the Company's business, results
of operations, financial condition, and stock price; the effect of
regional economic conditions on the Company's business, including
effects on purchasing decisions by consumers and businesses; the
ability of the Company to compete in markets that are highly
competitive and subject to rapid technological change; the ability
of the Company to manage frequent introductions and transitions of
products and services, including delivering to the marketplace, and
stimulating customer demand for, new products, services, and
technological innovations on a timely basis; the dependency of the
Company on the performance of distributors of the Company's
products. More information on these
risks and other potential factors that could affect the Company's
business and financial results is included in the Company's filings
with the SEC, including in the "Risk Factors" and
"Management's
Discussion and Analysis of Financial Condition and Results of
Operations" sections of the Company's most recently filed periodic
reports on Form 10-K and Form 10-Q and subsequent filings. The
Company assumes no obligation to update any forward-looking
statements or information, which speak as of their respective
dates.
BioLargo (QB) (USOTC:BLGO)
Historical Stock Chart
From Apr 2024 to May 2024
BioLargo (QB) (USOTC:BLGO)
Historical Stock Chart
From May 2023 to May 2024